Using p16/Ki-67 Immunostaining to Classify Atypical Squamous Metaplasia of the Cervix
Author Information
Author(s): Ann E. Walts, Bose Shikha
Primary Institution: Cedars-Sinai Medical Center
Hypothesis
Is p16/Ki-67 immunostaining useful in stratifying atypical squamous metaplasia (ASM) into reactive and cervical intraepithelial neoplasia (CIN) groups?
Conclusion
p16/Ki-67 immunostaining is effective in distinguishing between reactive changes and high-grade CIN in atypical squamous metaplasia.
Supporting Evidence
- 95% of benign squamous metaplasia cases were p16/Ki-67 negative.
- 81% of high-grade CIN cases were p16 band/Ki-67 positive.
- 70% of atypical squamous metaplasia cases could be reclassified as reactive changes.
Takeaway
Doctors can use special stains to tell if some abnormal cells in the cervix are just reacting to something or if they are a sign of something more serious.
Methodology
The study analyzed 80 cervical biopsies using p16/Ki-67 immunostaining and in-situ hybridization for HPV to classify atypical squamous metaplasia.
Potential Biases
Potential bias from subjective interpretation of staining results and exclusion of cases with discrepant diagnoses.
Limitations
The study relied on a limited number of cases and may not represent all types of atypical squamous metaplasia.
Participant Demographics
Participants included 84 women aged 10 to 71 years, with a mean age of 36.6 years.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website